Eastgate Biotech Corp. engages in the development of novel formulations of natural compounds and pharmaceutical products. It intends to accomplish by developing its proprietary self-emulsifying drug delivery systems, predominantly forming nanoemulsions. The company was founded on September 8, 1999 and is headquartered in Toronto, ON.
Company profile
Ticker
ETBI
Exchange
Website
CEO
Anna E. Gluskin
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Former names
Eastgate Acquisitions Corp
SEC CIK
Corporate docs
ETBI stock data
Latest filings (excl ownership)
8-K
Departure of Directors or Certain Officers
16 Sep 19
15-12G
Securities registration termination
2 Aug 19
10-Q
2017 Q3
Quarterly report
4 Mar 19
10-Q
2017 Q2
Quarterly report
18 Dec 18
10-Q
2017 Q1
Quarterly report
17 Aug 18
8-K
Changes in Registrant's Certifying Accountant
8 Jun 18
8-K
Entry into a Material Definitive Agreement
4 May 18
10-K
2016 FY
Annual report
1 Mar 18
Latest ownership filings
No filings
Institutional ownership, Q4 2022
13F holders | Current |
---|---|
Total holders | 0 |
Opened positions | 0 |
Closed positions | 1 |
Increased positions | 0 |
Reduced positions | 0 |
13F shares | Current |
---|---|
Total value | 0.00 |
Total shares | 0.00 |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|